Company / PP&E per Share
Regeneron Pharmaceuticals PP&E per Share History
FY2016-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$32.69
FY2022
5-year range
$30.39 / $32.69
FY2018-FY2022
Trend
+7.6%
vs FY2021
Sector context
#5 of 191
Health Care
What the data says
Among 191 Health Care companies, Regeneron Pharmaceuticals is in the top 3% for pp&e per share. PP&E per Share has increased for 5 consecutive years, from $18.37 in FY2016 to $32.69 in FY2022.
Based on SEC 10-K filings.
32.69 in FY2022 with a 5-year CAGR of +9.8%. Top quartile in the Health Care sector.
Improved from $28.06 to $32.69 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +9.8%
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 191This company $32.69 Sector average $22.34
▼
+46.3% above sector average
Key checks
Key Insights
- In FY2022, pp&e per share increased 7.6% year-over-year.
- Ranks #5 out of 191 companies in the Health Care sector.
- Lowest pp&e per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.03 (safe zone, above 2.9 threshold)
- Strong profit margin: 32.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $32.69 | +7.6% |
| FY2021 | $30.39 | +8.3% |
| FY2020 | $28.06 | - |
| FY2019 | - | - |
| FY2018 | $22.15 | +8.2% |
| FY2017 | $20.47 | +11.4% |
| FY2016 | $18.37 | +28.2% |
As of FY2022 · SEC 10-K · Updated Jun 30, 2026